Conference Coverage

ASCO goes ahead online, as conference center is used as hospital


 

However, some of the material that would have been part of the annual meeting, which includes mostly educational sessions and invited talks, has been moved to another event, the ASCO Educational Program, to be held in August 2020.

“So I suppose, in the grand scheme of things, the meeting is going to be compressed a little bit,” Schilsky commented. “Obviously, we can’t deliver all the interactions that happen in the hallways and everywhere else at the meeting that really gives so much energy to the meeting, but, at this moment in our history, probably getting the science out there is what’s most important.”

Virtual exhibition hall

There will also be a virtual exhibition hall, which will open on May 29.

“Just as there is a typical exhibit hall in the convention center,” Schilsky commented, most of the companies that were planning to be in Chicago have “now transitioned to creating a virtual booth that people who are participating in the virtual meeting can visit.

“I don’t know exactly how each company is going to use their time and their virtual space, and that’s part of the whole learning process here to see how this whole experiment is going to work out,” he added.

Unlike some of the other conferences that have gone virtual, in which access has been made available to everyone for free, registration is still required for the ASCO meeting. But the society notes that the registration fee has been discounted for nonmembers and has been waived for ASCO members. Also, the fee covers both the Virtual Scientific Program in May and the ASCO Educational Program in August.

Registrants will have access to video and slide presentations, as well as discussant commentaries, for 180 days.

The article first appeared on Medscape.com.

Pages

Recommended Reading

COVID-19: Calls to NYC crisis hotline soar
MDedge Hematology and Oncology
COVID-19: No U.S. spike expected in pandemic-related suicidal ideation
MDedge Hematology and Oncology
Survey: Hydroxychloroquine use fairly common in COVID-19
MDedge Hematology and Oncology
New study of diabetes drug for COVID-19 raises eyebrows
MDedge Hematology and Oncology
Out-of-hospital cardiac arrests soar during COVID-19 in Italy
MDedge Hematology and Oncology
Hydroxychloroquine-triggered QTc-interval prolongations mount in COVID-19 patients
MDedge Hematology and Oncology
Multisociety roadmap eyes restarting elective cardiac cases
MDedge Hematology and Oncology
New angiotensin studies in COVID-19 give more reassurance
MDedge Hematology and Oncology
Evidence builds linking anticoagulation to COVID-19 survival
MDedge Hematology and Oncology
Societies offer advice on treating osteoporosis patients during pandemic
MDedge Hematology and Oncology